指南与共识复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

拯救脓毒症运动2026年儿童脓毒症与脓毒性休克管理国际指南

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
指南 / 共识 · Pediatr Crit Care Med · 2026-03-23
一句话结论拯救脓毒症运动2026儿童脓毒症与脓毒性休克管理国际指南发布61条声明,其中仅5条为强推荐,仅3条基于高或中等确定性证据。

该指南由68名国际专家(代表13个国际组织)及6名方法学家制定,采用PICO问题、系统评价与GRADE方法评估证据质量,并通过证据到决策框架形成推荐。共给出61条声明:5条强推荐、24条条件推荐、10条良好实践声明;22个PICO问题无法形成推荐,其中7个提供了「在我们的实践中」声明。与2020版指南相比,20条为新推荐,13条因清晰度和/或新证据更新,6条审查后未改变,22条因无新证据基于专家组共识沿用;仅3条推荐基于高或中等确定性证据。

要点

  • 指南共61条声明:5条强推荐、24条条件推荐、10条良好实践声明,22个PICO问题无法形成推荐。
  • 仅3条推荐基于高或中等确定性证据,大多数方面证据质量仍相对较低。
  • 22个无法形成推荐的问题中,7个提供了「在我们的实践中」声明,用于证据不确定时提供基于实践模式的指导。
  • 与2020版相比:20条新推荐、13条更新、6条未改变、22条基于共识沿用。
  • 适用人群为儿童(包括婴儿、学龄儿童和青少年)脓毒症或脓毒性休克。

适用人群与场景

  • 儿童(包括婴儿、学龄儿童和青少年)脓毒症或脓毒性休克患者。

研究设计与关键结果

  • 指南由68名国际专家(代表13个国际组织)及6名方法学家制定,采用PICO问题、系统评价与GRADE方法评估证据质量,并通过证据到决策框架形成推荐。
  • 共提供61条声明:5条强推荐、24条条件推荐、10条良好实践声明。
  • 22个PICO问题无法形成推荐,其中7个提供了「在我们的实践中」声明。
  • 与2020版指南相比:20条新推荐、13条因清晰度和/或新证据更新、6条审查后未改变、22条基于专家组共识沿用(认为无新证据)。
  • 仅3条推荐基于高或中等确定性证据。

证据类型、等级与局限

  • 证据类型:国际指南(拯救脓毒症运动),采用GRADE方法评估证据质量,推荐分为强推荐或条件推荐,或良好实践声明。
  • 局限:原文指出大多数方面的证据质量仍相对较低,仅3条推荐基于高或中等确定性证据。

对床旁实践的改变

  • 原文未据此给出推荐。

指南或共识出处

  • 拯救脓毒症运动儿童脓毒症与脓毒性休克管理国际指南2026(Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026),发表于Pediatric Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To update evidence-based management recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with sepsis or septic shock.

DESIGN: A panel of 68 international experts, representing 13 international organizations, as well as six methodologists, was convened. A formal conflict-of-interest policy was developed at the onset of the process and applied throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and subgroup leads as well as within subgroups, served as an integral part of the guideline development process.

METHODS: New priority topics and recommendations from the prior guideline iteration were used to identify Population, Intervention, Control, and Outcomes (PICO) questions likely to have new or updated evidence. We conducted a systematic review to identify the best available evidence, summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or conditional, or as a good practice statement. "In our practice," statements were included when evidence was inconclusive to issue a recommendation but the panel felt that some guidance based on practice patterns may be appropriate.

RESULTS: The panel provided 61 statements on the management of children with sepsis or septic shock. Overall, five were strong recommendations, 24 were conditional recommendations, and ten were good practice statements. For 22 PICO questions, no recommendations could be made, but, for seven of these, "in our practice" statements were provided. Compared with the 2020 guidelines, 20 recommendations were new, 13 were updated for clarity and/or new evidence, six were reviewed but not changed, and 22 were carried forward based on consensus of the panel that new evidence was not available. Only three recommendations were based on high or moderate certainty of evidence.

CONCLUSIONS: Updated management guidelines were issued by a panel of international experts for the best care of children with sepsis or septic shock, acknowledging that most aspects of care continue to have relatively low quality of evidence.

来源:Pediatr Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Weiss SL, Peters MJ, Oczkowski SJW, et al. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026. Pediatr Crit Care Med. 2026. PMID: 41869844. doi:10.1097/PCC.0000000000003927

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。